ArrowMark Colorado Holdings Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Praxis Precision Medicines
PRAX
|
+$27.2M |
| 2 |
DFTX
Definium Therapeutics
DFTX
|
+$27.1M |
| 3 |
Generac Holdings
GNRC
|
+$18.2M |
| 4 |
RB Global
RBA
|
+$17.1M |
| 5 |
YSS
York Space Systems
YSS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ziff Davis
ZD
|
+$48.1M |
| 2 |
Procept Biorobotics
PRCT
|
+$42.5M |
| 3 |
Progyny
PGNY
|
+$37.9M |
| 4 |
Las Vegas Sands
LVS
|
+$32.1M |
| 5 |
Globus Medical
GMED
|
+$31.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.16% |
| 2 | Industrials | 22.52% |
| 3 | Technology | 16.05% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Financials | 7.79% |
Similar funds
ArrowMark Colorado Holdings's Q1 2026 Portfolio in Review
As of Q1 2026, ArrowMark Colorado Holdings held 331 positions worth $3.76B, down 17% from $4.54B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ArrowMark Colorado Holdings withdrew a net $559M in Q1 2026, closing 38 positions and reducing 142 holdings. Its most notable exit was Ziff Davis, an estimated $48.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.
Against the trend, ArrowMark Colorado Holdings opened a new position in Definium Therapeutics worth $30.1M.
- ArrowMark Colorado Holdings's largest Q1 2026 buy was Definium Therapeutics: 1,594,717 shares worth $30.1M.
- ArrowMark Colorado Holdings added most to Praxis Precision Medicines in Q1 2026, an estimated $27.2M increase.
- ArrowMark Colorado Holdings's biggest Q1 2026 reduction was Las Vegas Sands, cutting an estimated $32.1M.
- ArrowMark Colorado Holdings fully exited Ziff Davis in Q1 2026, selling an estimated $48.1M.
- ArrowMark Colorado Holdings's ten largest holdings make up 18% of its $3.76B portfolio in Q1 2026.
- ArrowMark Colorado Holdings opened 22 new positions and closed 38 in Q1 2026.
- ArrowMark Colorado Holdings's portfolio value fell 17% quarter-over-quarter to $3.76B.
Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.